Cellular Senescence Requires CDK5 Repression of Rac1 Activity

Molecular and Cellular Biology

Volumn 24, Issue 7, 2004, Pages 2808-2819

  Alexander, Kamilah ^a   Yang, Hai Su ^a,b   Hinds, Philip W ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA GALACTOSIDASE; CELL PROTEIN; CYCLIN DEPENDENT KINASE 5; GUANOSINE TRIPHOSPHATASE; PROTEIN PAK; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ARTICLE; CANCER INHIBITION; CELL AGING; CELL CYCLE; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; UPREGULATION;

ACTINS; ADENOVIRIDAE; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; CYTOSKELETON; ENZYME ACTIVATION; HUMANS; PURINES; RAC1 GTP-BINDING PROTEIN; RECOMBINANT FUSION PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 1642266407     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.7.2808-2819.2004     Document Type: Article

References (47)

1. KIP1 in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 21:3616-3631.
2. Banerjee, M., D. Worth, D. M. Prowse, and M. Nikolic. 2002. Pak1 phosphorylation on t212 affects microtubules in cells undergoing mitosis. Curr. Biol. 12:1233-1239.
3. Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
4. Bringold, F., and M. Serrano. 2000. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35:317-329.
5. Brookes, S., J. Rowe, M. Ruas, S. Llanos, P. A. Clark, M. Lomax, M. C. James, R. Vatcheva, S. Bates, K. H. Vousden, D. Parry, N. Gruis, N. Smit, W. Bergman, and G. Peters. 2002. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2936-2945.
6. Campisi, J. 1996. Replicative senescence: an old lives' tale? Cell 84:497-500.
7. Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85:573-583.
8. Collado, M., R. Medema, I. Garcia-Cao, M. Dubuisson, M. Barradas, J. Glassford, C. Rivas, B. Burgering, M. Serrano, and E. Lam. 2000. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 275:21960-21968.
9. Dai, C., and G. Enders. 2000. p16 INK4a can initiate an autonomous senescence program. Oncogene 19:1613-1622.
10. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20:1436-1447.
11. ARF tumor suppressor. Mol. Cell. Biol. 20:273-285.
12. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
13. Dulic, V., G. Beney, G. Frebourg, L. Drullinger, and G. Stein. 2000. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol. Cell. Biol 20:6741-6754.
14. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
15. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509-2514.
16. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
17. Hsueh, Y. P., E. Kim, and M. Sheng. 1997. Disulfide-linked head-to-head multimerization in the mechanism of ion channel clustering by PSD-95. Neuron 18:803-814.
18. Kissil, J. L., E. W. Wilker, K. C. Johnson, M. S. Eckman, M. B. Yaffe, and T. Jacks. 2003. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol. Cell 12:841-849.
19. Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
20. Kolquist, K. A., L. W. Ellisen, C. M. Counter, M. Meyerson, L. K. Tan, R. A. Weinberg, D. A. Haber, and W. L. Gerald. 1998. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19:182-186.
21. Lin, A. W., M. Barradas, J. C. Stone, L. van Aelst, M. Serrano, and S. W. Lowe. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12: 3008-3019.
22. Lundberg, A., W. Hahn, P. Gupta, and R. Weinberg. 2000. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:705-709.
23. MacCioni, R. B. 2001. Cdk5. Eur. J. Biochem. 268:1517.
24. Meijer, L., A. Borgne, O. Mulner, J. P. Chong, J. J. Blow, N. Inagaki, M. Inagaki, J. G. Delcros, and J. P. Moulinoux. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
25. Meyerson, M., C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddle, L. Ziaugra, R. L. Beijersbergen, M. J. Davidoff, Q. Liu, S. Bacchetti, D. A. Haber, and R. A. Weinberg. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795.
26. Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
27. Nikolic, M., M. M. Chou, W. Lu, B. J. Mayer, and L. H. Tsai. 1998. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 395:194-198.
28. Nobes, C. D., and A. Hall. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62.
29. Olson, M. F., A. Ashworth, and A. Hall. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270-1272.
30. Opitz, O. G., Y. Suliman, W. C. Hahn, H. Harada, H. E. Blum, and A. K. Rustgi. 2001. Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J. Clin. Investig. 108:725-732.
31. Philpott, A., E. B. Porro, M. W. Kirschner, and L. H. Tsai. 1997. The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning. Genes Dev. 11:1409-1421.
32. Rashid, T., M. Banerjee, and M. Nikolic. 2001. Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J. Biol. Chem. 276:49043-49052.
33. Ren, X. D., and M. A. Schwartz. 2000. Determination of GTP loading on Rho. Methods Enzymol. 325:264-272.
34. INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22:5157-5172.
35. Ridley, A. J. 1999. Rho family proteins and regulation of the actin cytoskeleton. Prog. Mol. Subcell. Biol. 22:1-22.
36. Sahai, E., and C. J. Marshall. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer 2:133-142.
37. Schmitt, C. A., J. S. Fridman, M. Yang, S. Lee, E. Baranov, R. M. Hoffman, and S. W. Lowe. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335-346.
38. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
39. Sui, G., C. Soohoo, E. B. Affar, F. Gay, Y. Shi, W. C. Forrester, and Y. Shi. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515-5520.
40. Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
41. Tiemann, F., and P. W. Hinds. 1998. Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J. 17:1040-1052.
42. Tiemann, F., K. Musunuru, and P. W. Hinds. 1997. In D. M. Swallow and Y. Edwards (ed.), Protein dysfunction in human genetic diseases, p. 163-185. BIOS Scientific Publishers, Oxford, United Kingdom.
43. Xu, H. J., Y. Zhou, W. Ji, G. S. Perng, R. Kruzelock, C. T. Kong, R. C. Bast, G. B. Mills, J. Li, and S. X. Hu. 1997. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15:2589-2596.
44. Yamamoto, M., N. Marui, T. Sakai, N. Morii, S. Kozaki, K. Ikai, S. Imamura, and S. Narumiya. 1993. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene 8:1449-1455.
45. Yang, H. S., and P. W. Hinds. 2003. Increased Ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype. Mol. Cell 11:1163-1176.
46. Zhong, J. L., M. D. Banerjee, and M. Nikolic. 2003. Pak1 and its T212 phosphorylated form accumulate in neurones and epithelial cells of the developing rodent. Dev. Dyn. 228:121-127.
47. Zhu, J., D. Woods, M. McMahon, and J. M. Bishop. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997-3007.